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The Embryonic Self-Evaluative Privilege: A
Primer for Health Care Lawyers
Thomas F. O'Neil IHI*
Adam H. Charnes**

INTRODUCTION

That health care fraud is the top law enforcement priority of
the 1990s is hardly debatable. Not surprisingly, as investigations, lawsuits, and criminal convictions under Medicare fraud
and abuse and other laws proliferate, an increasing number of
providers, manufacturers, and other entities in the health care
field are "cleaning house" before falling under regulatory scrutiny by administrative agencies such as the Department of Justice. Corporate directors, upper-echelon management, and inhouse counsel are essentially concluding that it is preferable to
identify and address compliance problems before receiving an
enforcement subpoena or a coercive demand from a whistle
blower. Moreover, such internal audits are encouraged by the
corporate provisions of the federal sentencing guidelines,' which
authorize meaningful reductions in criminal sentences for corporations that have in place a program to prevent and detect violations of the law.
While an internal corporate audit designed to ferret out misconduct quite clearly offers several tactical-to say nothing of
* Thomas O'Neil is Chief Litigation Counsel to MCI Communications Corporation and its affiliates. A 1982 graduate of the Georgetown University Law Center,
Mr. O'Neil clerked for the Honorable Alexander Harvey II, United States District
Court for the District of Maiyland, and was an Assistant United States Attorney for
the District of Maryland from 1986 to 1989. Until December 1995, Mr. O'Neil was a
partner of Hogan & Hartson L.L.P., where he represented many individuals and corporations in high-profile administrative, grand jury, and congressional investigations
of public corruption; production and distribution of drugs and medical devices; and, in
particular, health care fraud and abuse.
** Adam Charnes is Associate Litigation Counsel to MCI Communications Corporation and its affiliates. A 1991 graduate of the Harvard Law School, Mr. Charnes
clerked for the Honorable J. Harvie Wilkinson III, United States Court of Appeals
for the Fourth Circuit, and the Honorable Anthony M. Kennedy, Associate Justice,
Supreme Court of the United States. Prior to joining MCI, he was an associate with
the Washington, D.C. office of Hogan & Hartson L.L.P.
1.
UNITED STATES SENTENCING COMM'N, GUIDELINES MANUAL § 8C2.5(f) & (g)
(Nov. 1, 1995).
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ethical-advantages, it is not risk free. Certainly, the greatest
concern is that the information unearthed during the internal
audit will fall into hostile hands, thereby becoming a skewer
rather than a shield. Under such circumstances, the applicability
of various evidentiary privileges that can be used to withhold
the production of the analysis is of paramount importance. In
the context of internal investigations, counsel often cannot rely
with total confidence on the most frequently invoked protections-the attorney-client privilege 2 and the work product
doctrine.3

As a final refuge, litigants seeking to avoid producing internal
audit materials are now turning to the self-evaluative privilege
(also known, more awkwardly, as the privilege of self-critical
analysis). Born in the health care context, this qualified privilege was developed to promote the public interest by encouraging corporate self-policing. To date, the federal courts have
recognized this concept only under limited circumstances, and
its scope has been restricted. This article provides an explanation of the self-evaluative privilege and assists counsel who are

unfamiliar with this still evolving evidentiary barrier as it applies
to civil litigation, government subpoenas, grand jury investigations, and qui tam actions.
I.

THE BIRTH AND DEVELOPMENT OF THE SELFEVALUATIVE PRIVILEGE

A.

Evidentiary Privileges: An Overview

Rule 501 of the Federal Rules of Evidence authorizes the federal courts to apply the law of privileges as "governed by the
principles of the common law as they may be interpreted by the
2. By way of example, assertions of the attorney-client privilege are likely to fall
on deaf judicial ears if the investigation is not conducted by (or perhaps at the direction of) the company's attorneys, or if the investigators interview persons not employed by the company. See generally Upjohn v. United States, 449 U.S. 383 (1981).
3. The attorney's work product is protected only if it is prepared in anticipation of
litigation or for trial. See EDNA S. EPSTEIN & MICHAEL M. MARTIN, THE ATtORNEY-CLIENT PRIVILEGE AND THE WORK-PRODUCT DOCTRINE 114-15 (2d ed. 1989).
Although the doctrine generally covers materials created before the litigation actually
begins, courts differ as to when litigation is sufficiently likely and whether the materials must have been created with an eye toward a specific claim. Id. at 118-21. To
maximize the likelihood of applicability, at the outset of an internal investigation
counsel should, if possible, memorialize in writing the potential litigation in anticipation of which the investigation has been initiated.
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courts of the United States in light of reason and experience. '
Although Rule 501 appears on its face to bestow on the federal
courts sweeping authority to develop a federal common law of
privilege, the Supreme Court has interpreted the rule narrowly. 5
As the Court has repeatedly explained, "'the public ...

has a

right to every man's evidence' . . 6 Privileges contravene this
"fundamental principle"'7 and "are not lightly created nor expansively construed, for they are in derogation of the search for
truth."'8 In light of these principles, a heavy burden rests on a
party seeking judicial recognition or expansion of an evidentiary
privilege.
B.

The Scope of the Self-Evaluative Privilege

The self-evaluative privilege was first formulated in Bredice v.
Doctors Hospital,Inc.,9 a medical malpractice case. The plaintiff
there sought discovery of the minutes and reports of hospital
boards or committees concerning the death of the plaintiff's decedent. The staff meetings at issue had been instituted to improve clinical care at the hospital and were required by the Joint
Commission on Accreditation of Hospitals. 10 The federal district court held that such material was not discoverable. Noting
that confidentiality was essential to the "effective functioning"
of the staff meetings, and that, in turn, those discussions were
"essential to the continued improvement in the care and treatment of patients," the court found that such internal deliberations would not occur if subject to the discovery process. 1'
Based on the "overwhelming public interest" in the continued
effective functioning of the hospital staff meetings, the Bredice
4. FED. R. EviD. 501. State privilege laws, however, are applicable in civil proceedings with respect to "an element of a claim or defense as to which State law
supplies the rule of decision." Id.
5. See University of Pa. v. EEOC, 493 U.S. 182, 189 (1990) ("although Rule 501
manifests a congressional desire 'not to freeze the law of privilege' but rather to provide the courts with flexibility to develop rules of privilege on a case-by-case basis, we

are disinclined to exercise this authority expansively") (citation omitted).
6. United States v. Nixon, 418 U.S. 683, 709 (1974) (quoting Branzburg v. Hayes,
408 U.S. 665, 688 (1972)).
7. University of Pa., 493 U.S. at 189 (quoting Trammel v. United States, 445 U.S.

40, 50 (1980)).
8. Nixon, 418 U.S. at 710.
9. 50 F.R.D. 249 (D.D.C. 1970), aff'd without opinion, 479 F.2d 920 (D.C. Cir.
1973). At the time of the action, the District of Columbia did not have a statutory
privilege to protect the confidentiality of the peer review process. See infra note 13.
10. Id. at 249-50.
11. Id. at 250.
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court held that the minutes of these gatherings were not discoverable "[a]bsent evidence of extraordinary circumstances."12
In the wake of Bredice, courts have applied the qualified selfevaluative privilege in a host of different contexts. 13 Courts
have applied it to an analysis of an Amtrak accident, and recommendations issued in light of it, in an action for injuries sustained in the accident; 14 studies of injuries caused in products
liability cases; 15 an internal review and report on internal quality
controls of an accounting firm in securities fraud litigation; 16 retrospective environmental analyses of past conduct and resulting
environmental consequences in an action under federal environmental law; 17 a television network's evaluation of its own preparation of a news program in a libel action; 18 a self-analysis of a
company's pending Food and Drug Administration application
for a new drug in patent litigation;' 9 and an evaluation of a company's affirmative action policies. 20 Recognition of the privilege, however, is far from uniform. Indeed, there are significant
discrepancies in the reception accorded the theory even among
federal courts addressing the privilege in similar contexts. 21 It is
impossible, therefore, to generalize about the circumstances in
which the privilege will, or will not, be recognized; the law of the
jurisdiction in which the litigation occurs must be analyzed
thoroughly.22
12. Id. at 251.
13. Certain state legislatures have enacted a version of the privilege; the most
common example is for hospital peer review processes, such as that at issue in Bredice. See Susan 0. Scheutzow & Sylvia L. Gillis, Confidentiality and Privilege of Peer
Review Information: More Imagined Than Real, 7 J.L. & HEALTH 169, 186-192 (1992/
1993); Charles D. Creech, Comment, The Medical Review Committee Privilege:A JurisdictionalSurvey, 67 N.C. L. REV. 179 (1988). The degree of protection afforded by
these statutes obviously differs by state, and, therefore, the applicable state statute
(and case law interpreting it) must be carefully reviewed.
14. Granger v. National R.R. Passenger Corp., 116 F.R.D. 507 (E.D. Pa. 1987).
15. Bradley v. Melroe Co., 141 F.R.D. 1 (D.D.C. 1992); Lloyd v. Cessna Aircraft
Co., 74 F.R.D. 518, 521-522 (E.D. Tenn. 1977).
16. In re Crazy Eddie Sec. Litig., 792 F. Supp. 197, 205-06 (E.D.N.Y. 1992).
17. Reichold Chems., Inc. v. Textron, Inc., 157 F.R.D. 522 (N.D. Fla. 1994).
18. Lasky v. American Broadcasting Co., 5 Fed. R. Serv. 3d (Callaghan) 1366
(S.D.N.Y. 1986).
19. NeoRx Corp. v. Immunomedics, Inc., 877 F. Supp. 202 (D.N.J. 1993).
20. Sheppard v. Consolidated Edison Co. of N.Y., 893 F. Supp. 6 (E.D.N.Y. 1995).
21. For example, some federal courts have applied the privilege to a company's
analysis of its affirmative action policies, see, e.g., Sheppard, 893 F. Supp. 6, while
other federal courts have rejected application of the privilege in precisely the same
context, see, e.g., Tharp v. Sivyer Steel Corp., 149 F.R.D. 177 (S.D. Iowa 1993).
22. The unsettled recognition of the privilege and a company's fear that, sometime
in the future, it might be hauled into court both undermine the usefulness of the self-
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Generally, courts recognizing the privilege have established
the following parameters. First, the information must have re-

sulted from a critical self-analysis performed by the party seeking the protection. Second, there must be a strong public
interest in promoting the "free flow" or exchange within the en-

tity (for example, the corporation) of the class of information
that the party is seeking to protect. Third, the party invoking

the privilege must demonstrate that the "flow" would cease if
the class of information were discoverable.23 If all three of these

conditions are satisfied and the privilege has not been waived
(in other words, the information has not been disclosed to a
third party), then the information is entitled to a qualified protection from discovery.
As a qualified privilege, the self-evaluative privilege can be
overcome if the party seeking the information demonstrates sufficient need for it.24 The courts disagree about the standards
governing such a showing. Some courts follow Bredice and require "extraordinary necessity" or "exceptional necessity"

before disclosing the privileged information.2 5 Others, by contrast, apply a more lenient balancing test to determine whether

other interests outweigh those underlying the privilege.26 Under
this latter approach, courts generally have recognized two rationales. First, some courts have focused on a party's need for the
information at issue-for example, when there is no other

source of the information and the party seeking it will be
evaluative privilege as a tool to be used proactively to protect confidential and potentially embarrassing or harmful self-analyses.
23. See, e.g., Dowling v. American Haw. Cruises, Inc., 971 F.2d 423, 425-26 (9th
Cir. 1992); Reichold Chems., 157 F.R.D. at 526. This widely accepted formulation
derives from Note, The Privilege of Self-Critical Analysis, 96 HARV. L. REV. 1083,
1086 (1983). Some courts add a fourth requirement: the document was prepared with
the expectation that it would remain confidential and that, in fact, it remained confidential. See, e.g., Dowling, 971 F,2d at 426. This latter requirement, however, can be
conceived merely as a requirement that the privilege not be waived, comparable to
the waiver standard to which the attorney-client privilege is subject. See EPSTEIN &
MARTIN,

supra note 3, at 59-82.

24. Robert J. Bush, Stimulating Corporate Self-regulation-The Corporate SelfEvaluative Privilege:ParadigmaticPreferentialismor PragmaticPanacea,87 Nw. U. L.
REv. 597, 645 (1993).
25. See, e.g., Mewborn v. Heckler, 101 F.R.D. 691, 692-93 (D.D.C. 1984) (citations
omitted).
26. See, e.g., Harding v. Dana Transp., Inc., 914 F. Supp. 1084, 1100 (D.N.J. 1996);
Wei v. Bodner, 127 F.R.D. 91, 100-01 (D.N.J. 1989); Hardy v. New York News, Inc.,
114 F.R.D. 633, 641-42 (S.D.N.Y. 1987).
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prejudiced by its unavailability. 27 Second, courts have also held
that certain public policies outweigh the interests served by the
privilege, most commonly when the evaluative process itself is
challenged in the litigation. For example, in Todd v. South
Jersey Hospital System,28 the plaintiff alleged that the defendant
hospital's alleged failure to respond to recommendations by its
quality improvement committee constituted "administrative
negligence" and resulted in a physician's medical malpractice.
The court held that the interest in preserving confidentiality was
outweighed by policy interests of shedding light on the defendant's alleged negligence.29 Similarly, discovery was allowed in
Wei v. Bodner,3 ° where a physician's Sherman Act claims alleged
that the antitrust violation consisted, in part, of the actions of a
hospital's quality assurance committee.31 Other courts have
broadly held that the public policies advanced by the federal antitrust 32 and equal employment opportunities 33 laws simply outweigh the interests underlying the privilege.
II.

LIMITATIONS ON THE PRIVILEGE

The self-evaluative privilege was initially embraced fervently
by defense counsel, who viewed it as a potentially meaningful
protection for internal analyses conducted by businesses and
their counsel. In circumstances in which the applicability of the
attorney-client privilege or the work product doctrine was uncertain or questionable, counsel eagerly turned toward the developing self-evaluative privilege as the saving grace, a way to
conduct freely internal investigations and other self-analyses
without creating the risk of generating a report or other work
product that one day could be used against their client. Subsequent developments, however, have dashed that hope. As explained below, even when the self-evaluative privilege is
recognized by the courts-which itself is far from certain-its
27. See, e.g., Todd v. South Jersey Hosp. Sys., 152 F.R.D. 676, 683 (D.N.J. 1993);
Lasky v. American Broadcasting Co., 1986 WL 9223, at *2 (S.D.N.Y. Aug. 13, 1986);
McClain v. College Hosp., 492 A.2d 991, 993 (N.J. 1985).
28. 152 F.R.D. 676.
29. Id. at 683-84.
30. 127 F.R.D. 91.
31. Id. at 101. See also Memorial Hosp. v. Shadur, 664 F.2d 1058, 1062-63 (7th
Cir. 1981) (per curiam).
32. See, e.g., Morgenstern v. Wilson, 133 F.R.D. 139, 142 & n.3 (D. Neb. 1990).
33. See, e.g., Tharp v. Sivyer Steel Corp., 149 F.R.D. 177, 183-84 (S.D. Iowa 1993);
Webb v. Westinghouse Elec. Corp., 81 F.R.D. 431, 433 (E.D. Pa. 1978).
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benefits will often be chimerical to health care entities investigating possible violations of law by their employees or agents.
A.

Underlying Facts Are Unprotected

A majority of courts recognizing the self-evaluative privilege
have held that it covers only the analysis and recommendations
resulting from self-evaluations and not the underlying facts unearthed during the audit. 34 Also unprotected are any documents
created independently from the evaluation, but reviewed during
the investigation or self-analysis.35 These same principles apply,
of course, to other privileges; for example, an otherwise nonprivileged, preexisting document cannot be shielded merely because it was reviewed or analyzed by counsel, and a fact told by
a client to counsel remains discoverable through other sources.
Therefore, in theory, these limitations seem appropriate and
logical in the context of the self-evaluative privilege. However,
the reason the underlying facts come to light during a self-analysis is vastly different from that during the production of factual
information during, or in anticipation of, a controversy among
the parties. Self-analysis is an entity's completely voluntary investigation of the facts; discovery, for example, is a required part
of the litigation process, and an attorney's evaluation of a claim
is necessary as a prelude to litigation. Counsel should stress this
distinction and present a solid policy argument when facing a
judge.
Counsel must very carefully evaluate the risk of being compelled to present underlying facts and documents before initiating an internal investigation or self-evaluation. Even if frank
criticisms of company policy may be withheld from future discovery, those portions of a written report that compile, organize,
and present all pertinent underlying facts nonetheless may well
be disgorged, providing opposing parties with an easy road map
for proving their claims, as well as admissions of a party opponent that are extremely useful during litigation. To avoid this
possibility, factual discussions in a written self-evaluative report
should be interwoven with analysis and recommendations to the
extent possible. (Counsel should consider, however, that a court
might refuse to enforce the privilege at all if it believes that
34. See, e.g., In re Crazy Eddie Sec. Litig., 792 F. Supp. 197, 205 (E.D.N.Y. 1992);
Todd v. South Jersey Hosp. Sys., 152 F.R.D. 676, 682 (D.N.J. 1993); Wei v. Bodner,
127 F.R.D. 91, 100 (D.N.J. 1989).
35. See EPSTEIN & MARTIN, supra note 3, at 23-24.
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counsel intentionally commingled facts and analysis in an effort
to expand the coverage of the privilege.) Although obviously
reducing the utility of the investigation-perhaps fatally-consideration should also be given to memorializing in writing only
the analytical results of the self-analysis, and not the factual
compilation. Whether such an approach will be viable depends

on the circumstances.
B.

Government Subpoenas

The self-evaluative privilege may not be asserted against the
United States. This principle has been applied both during the

course of civil litigation initiated by the government against the
party asserting the privilege 36 and in proceedings initiated by administrative agencies to enforce subpoenas resisted on the basis
of the privilege.37
Federal courts have advanced two rationales for this counterintuitive position. 38 First, several have viewed Congress' provi-

sion of broad investigatory and subpoena powers to the
administrative agency in question as a policy determination regarding the scope of discovery that the courts are not free to

override.39 These rulings have distinguished the context of civil

discovery, "where courts have broad discretion under the Fed-

eral Rules of Civil Procedure to apply a particular privilege,"
from an agency acting pursuant to Congress' specific authorization to use broad subpoena power. ° This rationale has been
applied in proceedings to enforce subpoenas issued by, among
other agencies, the Internal Revenue Service,41 the Federal
Trade Commission,42 and the Secretary of Labor.43 There is no
36. See, e.g., United States v. Dexter Corp., 132 F.R.D. 8, 8-10 (D. Conn. 1990).
37. See, e.g., FTC v. TRW, Inc., 628 F.2d 207, 210-11 (D.C. Cir. 1980); Reich v.
Hercules, Inc., 857 F. Supp. 367, 371 (D.N.J. 1994). State courts have applied the
same principle to reject attempts to use the privilege to withhold information requested by state agencies. See, e.g., Office of Consumer Counsel v. Department of
Pub. Util. Control, 665 A.2d 921, 925-26 (Conn. Super. Ct. 1994).
38. After all, there is no indication in Federal Rule of Evidence 501, from which
all privileges recognized in federal court derive, that the United States is entitled to
preferential treatment and may obtain information that would be beyond the reach of
private litigants.
39. See, e.g., TRW, Inc., 628 F.2d at 211; United States v. Noall, 587 F.2d 123, 126
(2d Cir. 1978) (Friendly, J.), cert. denied, 441 U.S. 923 (1979); Hercules, Inc., 857 F.
Supp. at 371.
40. Hercules, Inc., 857 F. Supp. at 371.
41. See Noall, 587 F.2d at 126.
42. See TRW, Inc., 628 F.2d at 211.
43. See Hercules, Inc., 857 F. Supp. at 371.
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reason to believe that a court would not apply the same principle, for example, to subpoenas issued by the Office of Inspector
General of the Department of Health and Human Services or
the Food and Drug Administration, given the similarly broad
subpoena and investigatory powers accorded those entities by
Congress.
Some courts, moreover, have invoked a more sweeping theory. In enacting the federal law that the government seeks to
enforce, these court have reasoned, Congress "declar[ed] what
is in the public interest."44 A court would undermine this determination, according to this view, by recognizing the privilege
and thereby determining on its own that the public interest demanded that the agency not have access to the very information
Congress sought to provide it.45 Some courts have also determined that the application of the privilege would undermine
"the strong public interest in having administrative investiga46
tions proceed expeditiously and without impediment.
In sum, the courts have refused to permit parties to use the
self-evaluative privilege to thwart federal agencies' ability to obtain documents otherwise within their subpoena power. This restriction obviously severely reduces the utility of the privilege to
businesses-such as health care entities-that operate in industries heavily regulated by the federal government.
C. Grand Jury Investigations
That the self-evaluative privilege has no force in the grand
jury chamber follows a fortiori from the principle that it is inapplicable against the government in civil litigation or administrative proceedings, and so a federal district court in Maryland held
in In re Grand Jury Proceedings,47 the only currently reported
case on point. In re Grand Jury Proceedingsinvolved an investigation into a company's compliance with the Food, Drug, and
Cosmetics Act,48 possible false statements made by the company
to the Food and Drug Administration (FDA), and possible obstruction of FDA inspections. The grand jury issued subpoenas
requiring the production of audits of the company's operations
by an outside consultant. The district court rejected the com44.

United States v. Dexter Corp., 132 F.R.D. 8, 9 (D. Conn. 1990).

45. Id.; TRW, Inc., 628 F.2d at 210-11; Hercules, Inc., 857 F. Supp. at 371.
46. TRW, Inc., 628 F.2d at 210.
47. 861 F. Supp. 386 (D. Md. 1994).
48. 21 U.S.C. §§ 301-394 (Supp. IV 1992).
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pany's efforts to resist the subpoena on the basis of the self-evaluative privilege.
Noting that courts had refused to apply the privilege to documents sought by a government agency, the district court concluded it should not be recognized in grand jury proceedings.
First, the court observed that the United States Supreme Court
has refused to exercise "expansively" its authority to formulate
new evidentiary privileges, for "[t]he balancing of competing interests" that underlie recognition of a privilege "is particularly a
legislative function. ' 49 Next, the court discussed the "wide latitude" historically accorded the grand jury, 50 given that "[g]rand
jury proceedings are constitutionally mandated . . ., and [the
grand jury's] constitutional prerogatives are rooted in long centuries of Anglo-American history."' 51 In light of these considerations, the court held that permitting the self-evaluative privilege
would constitute a "usurpato limit the powers of the grand jury
' 52
tion of the 'legislative function."'

The court rejected the company's argument that subjecting
self-evaluative reports to grand jury subpoenas would have a
chilling effect on other health care entities contemplating internal evaluations. While acknowledging the importance of this
concern, the court found it insufficient for three reasons. First,
there remained sufficient incentives for companies to obtain independent audits even if the results were subject to grand jury
subpoena. Second, perhaps the audit would not be admissible at
any eventual criminal trial, although the court failed to explain
its basis for this suggestion. Third, these policy considerations
should be addressed to Congress or the executive branch: "Absent direction from the legislature or the Executive, those concerns should not be permitted to outweigh the broad latitude
historically accorded grand jury investigations without more
compelling reason than appears to exist in this case at this
time."5 3
The prospect of successfully using the self-evaluative privilege
to protect from production materials generated as a result of an
internal investigation is slim. Given the serious nature of a
49. 861 F. Supp. at 389 (quoting University of Pa. v. EEOC, 493 U.S. 182, 189
(1990)).
50. Id. (quoting United States v. Calandra, 414 U.S. 338, 343-45 (1974)).

51. Id. (quoting Branzburg v. Hayes, 408 U.S. 665, 687 (1972) (internal quotations
omitted)).
52. Id. at 390 (quoting University of Pa., 493 U.S. at 189).
53. Id.
http://lawecommons.luc.edu/annals/vol5/iss1/4

10

O'Neil and Charnes: The Embryonic Self-Evaluative Privilege: A Primer for Health Care

1996]

The Self-Evaluative Privilege

grand jury proceeding, the inapplicability of the self-evaluative
privilege may present the greatest impediment to entities wishing to "clean house." The courts and legislature may wish to
consider the benefits society loses by giving the grand jury this
authority.
D.

Qui Tam Actions

An increasingly common threat to health care entities is qui
tam, or whistle blower, litigation under the False Claims Act
(FCA).54 The FCA provides for treble damages and mandatory
civil penalties of between $5000 and $10,000 for each false or
fraudulent claim filed with the government. Moreover, private
parties (known as "relators") may bring a qui tam action under
the FCA on behalf of the United States, and, if successful, these
relators may receive a percentage of any sums the United States
receives from the defendants in the litigation. 5 Since the 1986
amendments to the FCA, more than 1100 qui tam cases56 have
been filed, with a total recovery of more than $1 billion. Qui
tam actions are increasingly targeting health care misconduct
and are likely to become a permanent fixture in the fraud and
abuse landscape. 7
In light of the increasing importance to health care lawyers of
the FCA and its qui tam provisions, the recent district court decision in the qui tam case of United States ex rel. Falsettiv. Southern Bell Telephone & Telegraph Co.,58 is particularly noteworthy.
The relator alleged that the defendant had billed the government for out-of-service telephone access lines, failed to provide
required refunds, and billed the government for services that it
had not provided. The qui tam relator sought discovery of documents that were related to any internal investigations or audits
the defendant had conducted with respect to an investigation of
the defendant by the state's public service commission. Rejecting the defendant's claim of privilege, the district court held
54.

31 U.S.C. §§ 3729-3732 (1994).

55. Id. § 3730. For more information about qui tam actions under the False
Claims Act, see David J. Ryan, The False Claims Act: An Old Weapon with New
Firepower Is Aimed At Health Care Fraud, 4 ANNALS HEALTH L. 127 (1995).

56. Thomas F. O'Neil III et al., The Buck Stops Here: Preemption of Third-Party
Claims by the False Claims Act, 12 J. CONTEMP. HEALTH L. & POL'Y 41 (1996).
57.
58.

Id. at 42-44 & n.5; Ryan, supra note 55.
915 F. Supp. 308 (N.D. Fla. 1996).
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that the self-evaluative privilege is inapplicable in qui tam
actions.59
The court held that in enacting the FCA, Congress considered
and settled the competing policy concerns of disclosure versus
protection, foreclosing judicial recognition of the privilege in the
qui tam context. According to the court, "Congress has provided its own version of a self-critical analysis privilege" in those
provisions of the FCA that reduce the penalties applicable to
defendants who voluntarily disclose wrongdoing to the government within thirty days of discovering the violation. 60 Under
such circumstances, the court reasoned, judicial recognition of
more extensive evidentiary protections would be inappropriate .61
CONCLUSION

The goal of the self-evaluative privilege is to encourage voluntary, confidential self-analysis. It seems axiomatic that businesses should be encouraged to evaluate the propriety of their
policies and practices and the conduct of their employees and
agents. Against this laudatory public interest must be balanced
the general principle that, in litigation, the litigants and arbiter
are entitled to "every man's evidence." The privilege, in this
sense, no doubt frustrates important countervailing interestssuch as punishing wrongdoers and lawbreakers and entitling victims and other plaintiffs to a fair and full opportunity to prove
their cases.
Perhaps because the benefits of the self-evaluative privilege
seem to many courts diffuse compared to the very real consequences of nondisclosure in particular cases, it offers only tenuous protection, at best, when counsel's primary concern in
determining whether to conduct an internal investigation or
other self-analysis is the potential of future disclosure to a federal governmental entity-whether a regulator, the United
States as litigant, or a grand jury. In other circumstances, when
disclosure to a future private litigant is the primary concern, the
privilege may impart some protections, depending, of course, on
the nature of the claim, the forum in which it is litigated, and the
provisions of state law.
59. Id. at 313.
60. Id. (citing the False Claims Act, 31 U.S.C. § 3729(a)(1-7)(A-C)).
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